Authors
Andreas Røder
Published in
European urology focus. Jul 14, 2026. Epub Jul 14, 2026.
Abstract
The modest mortality benefit of prostate-specific antigen screening is inseparable from overdiagnosis and harm, challenging its role as a population strategy.
PMID:
42448506
Bibliographic data and abstract were imported from PubMed on 15 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0